A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

NCT05929066 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

2300

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight
Osteoarthritis, Knee
Obstructive Sleep Apnea

Interventions

DRUG: Retatrutide
DRUG: Placebo

Sponsor

Eli Lilly and Company